Omthera Pharmaceuticals Inc (OMTH.OQ)
13.29USD
1:46pm EDT
$-0.03 (-0.23%)
$13.32
$13.27
$13.37
$13.27
5,500
--
$13.74
$5.73
About
Overall
| Beta: | -- |
| Market Cap (Mil.): | $325.20 |
| Shares Outstanding (Mil.): | 24.41 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| OMTH.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 34.45 | 32.18 |
| EPS (TTM): | -- | -- | -- |
| ROI: | -- | -2.81 | 18.91 |
| ROE: | -- | -3.51 | 19.87 |
AstraZeneca buys heart firm Omthera for up to $443 million
LONDON - AstraZeneca is to buy Omthera Pharmaceuticals for as much as $443 million to build up its cardiovascular drug business, a priority area for Britain's second-biggest drugmaker.
AstraZeneca buys heart drug firm Omthera for up to $443 mln
LONDON, May 28 - AstraZeneca has agreed to buy Omthera Pharmaceuticals for up to $443 million to build up its cardiovascular drug business, which Britain's second biggest drugmaker has previously identified as a priority area.
AstraZeneca buys heart drug firm Omthera for up to $443 mln
LONDON, May 28 - AstraZeneca has agreed to buy Omthera Pharmaceuticals for up to $443 million to build up its cardiovascular drug business, which Britain's second biggest drugmaker has previously identified as a priority area.
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
|
Provider: GlobalData
|
$250.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
|
Provider: GlobalData
|
$250.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

